B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

COX2

MOLECULAR TARGET

cytochrome c oxidase subunit II

UniProt: P00403NCBI Gene: 45134 compounds

COX2 (cytochrome c oxidase subunit II) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting COX2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Celecoxib1.795
2bdb chembl50818620.691
3bdb chembl5084744 us20240182406 example 20.691
4bdb chembl5093683 us20240182406 example 10.691

About COX2 as a Drug Target

COX2 (cytochrome c oxidase subunit II) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented COX2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

COX2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.